Microtubule-Associated Protein Tau clinical trials
12 active trials name this biomarker in their eligibility criteria. Describe your situation to see which ones look like a fit.
- Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
- Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- A Study of LY3439539 in Participants With Alzheimer's Disease
- Alzheimer's Tau Platform: Master Protocol
- Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
- Alzheimer's Tau Platform: Regimen A - AADvac1
- Study of Tau Imaging With the Use of [18F]MK-6240 Tracer
- Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
- F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
- Sensory-Evoked Cortical Gamma Oscillation
- R21 Roche: 3-Way Tau Tracers in AD
Guides for people searching for a trial
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that name “Microtubule-Associated Protein Tau” in their eligibility criteria, at any level. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.